Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March-May 2020
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020..
We report off-label use patterns for medications repurposed for coronavirus disease 2019 (COVID-19) at 318 US hospitals. Inpatient hydroxychloroquine use declined by 80%, whereas corticosteroids and tocilizumab were initiated 2 days earlier in May versus March 2020. Two thirds of ventilated COVID-19 patients were already receiving corticosteroids during March-May 2020, resembling pre-COVID use in mechanically ventilated influenza patients.
Errataetall: |
CommentOn: Open Forum Infect Dis. 2020 Dec 15;8(2):ofaa617. - PMID 33553472 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
Open forum infectious diseases - 8(2021), 2 vom: 04. Feb., Seite ofaa616 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kadri, Sameer S [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Revised 10.11.2023 published: Electronic-eCollection CommentOn: Open Forum Infect Dis. 2020 Dec 15;8(2):ofaa617. - PMID 33553472 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1093/ofid/ofaa616 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM32116623X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM32116623X | ||
003 | DE-627 | ||
005 | 20231225175231.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/ofid/ofaa616 |2 doi | |
028 | 5 | 2 | |a pubmed24n1070.xml |
035 | |a (DE-627)NLM32116623X | ||
035 | |a (NLM)33556157 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kadri, Sameer S |e verfasserin |4 aut | |
245 | 1 | 0 | |a Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March-May 2020 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 10.11.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a CommentOn: Open Forum Infect Dis. 2020 Dec 15;8(2):ofaa617. - PMID 33553472 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020. | ||
520 | |a We report off-label use patterns for medications repurposed for coronavirus disease 2019 (COVID-19) at 318 US hospitals. Inpatient hydroxychloroquine use declined by 80%, whereas corticosteroids and tocilizumab were initiated 2 days earlier in May versus March 2020. Two thirds of ventilated COVID-19 patients were already receiving corticosteroids during March-May 2020, resembling pre-COVID use in mechanically ventilated influenza patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Comment | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a medications | |
650 | 4 | |a repurposed | |
650 | 4 | |a trends | |
700 | 1 | |a Demirkale, Cumhur Y |e verfasserin |4 aut | |
700 | 1 | |a Sun, Junfeng |e verfasserin |4 aut | |
700 | 1 | |a Busch, Lindsay M |e verfasserin |4 aut | |
700 | 1 | |a Strich, Jeffrey R |e verfasserin |4 aut | |
700 | 1 | |a Rosenthal, Ning |e verfasserin |4 aut | |
700 | 1 | |a Warner, Sarah |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Open forum infectious diseases |d 2014 |g 8(2021), 2 vom: 04. Feb., Seite ofaa616 |w (DE-627)NLM243576811 |x 2328-8957 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2021 |g number:2 |g day:04 |g month:02 |g pages:ofaa616 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/ofid/ofaa616 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 2021 |e 2 |b 04 |c 02 |h ofaa616 |